Related Experiment Video

Updated: Jun 6, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

[Diminishing borders between cardiology and cardiothoracic surgery: quo vadis?]

T Schilling1, R Bekeredjian, A Haverich

  • 1Klinik für Herz-, Thorax-, Transplantations- und Gefässchirurgie, Medizinische Hochschule, Carl-Neuberg-Strasse 1, 30625, Hannover, Deutschland. schilling.tobias@mh-hannover.de

Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|November 13, 2010
PubMed

Insights

Cardiology and cardiac surgery collaboration is vital for advancing cardiovascular medicine. Optimal patient therapy requires seamless cooperation between these fields for complex heart conditions.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Cardiac Surgery

Context:

  • Complex cardiovascular medicine necessitates a collaborative partnership between cardiology and cardiac surgery.
  • Challenges exist in treating coronary heart disease, heart valves, heart failure, and rhythm disorders.
  • Interventional techniques are increasingly adopted by cardiologists for procedures like valve implantation.

Purpose:

  • To explore the evolving landscape of cardiovascular medicine and the collaborative relationship between cardiology and cardiac surgery.
  • To identify key areas of shared challenges and advancements, including coronary revascularization, heart valve replacement, heart failure management, and rhythm therapy.

Summary:

  • Coronary revascularization for acute myocardial infarction now involves both interventional and surgical approaches.
  • Transcatheter and conventional techniques are being integrated for heart valve implantation, with new sutureless designs emerging.
  • Heart failure, a leading cause of hospitalization, is addressed through advanced diagnostics, heart assist devices, and cellular therapies.

Impact:

  • Enhanced collaboration between cardiology and cardiac surgery is crucial for optimal patient outcomes.
  • Transsectoral cooperation will drive innovation and improve therapeutic strategies in cardiovascular medicine.
  • A unified approach ensures comprehensive management of complex cardiovascular diseases.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...